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Abstract
Objectives—To characterize lipids and lipoproteins in a diverse school-based cohort and
identify features associated with discordance between low-density lipoprotein cholesterol (LDL-
C) and LDL particle (LDL-P).
Study design—Sixth grade children enrolled in the HEALTHY trial (n=2,384; mean age 11.3 ±
0.6 yr; 54.2% female) were evaluated for standard lipids, lipoprotein particles measured by
nuclear magnetic resonance, and homeostatic model of insulin resistance (HOMA-IR).
Characteristics of subgroups with values of LDL-C and LDL-P discordant by >20 percentile units,
an amount reasoned to be clinically significant, were compared.
Results—Four hundred twenty-eight (18%) of children were in the LDL-P < LDL-C subgroup
and 375 (16%) in the LDL-P > LDL-C subgroup. Those with LDL-P > LDL-C had significantly
higher BMI, waist circumference, HOMA-IR, triglycerides, systolic and diastolic blood pressure,
and reflected a greater Hispanic ethnic composition but fewer of black race than both the
concordant (LDL-P ≅ LDL-C) and opposite discordant (LDL-P < LDL-C) subgroups.
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Conclusions—There is as much lipoprotein cholesterol compositional heterogeneity in 6th
graders as has been described in adults and a discordant atherogenic phenotype of LDL-P > LDL-
C, common in obesity, is often missed when only LDL-C is considered. Conversely, many
children with moderate-risk cholesterol measures (75th to 99th percentile) have a lower LDL
particle burden.
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One of the modifiable risk factors for cardiovascular disease (CVD) is dyslipidemia, but the
optimal biomarker(s) to capture this risk is debated. Decades of evidence support the role of
cholesterol infiltration into the vascular wall in atherogenesis, with uptake of ectopic lipid
leading to foam cell and fatty streak formation. Cholesterol enters the arterial wall in
apolipoprotein B (apoB) containing lipoproteins, predominantly LDL, but the cholesterol
content of LDL particles (LDL-P) varies widely such that LDL cholesterol (LDL-C) is not
always an accurate estimate of LDL-P burden. Non-HDL-C (total cholesterol minus HDL-
C), captures the cholesterol content within all lipoprotein particles considered to be
atherogenic, correlates more strongly with LDL-P than LDL-C, and is currently
recommended as an alternate measure of atherosclerotic risk, especially in
hypertriglyceridemic adults(1) and children.(2) LDL-lowering treatment in children is of
proven benefit when LDL-C levels are extreme(3) but the continued substantial burden of
CVD suggests that the full spectrum of lipoprotein-related risk for optimal primary
prevention is neither adequately identified or managed.
There is incomplete prediction of risk by either LDL-C or non-HDL-C(4) and persistent
cardiovascular risk in the face of aggressive cholesterol lowering therapies.(5) Both may be
explained at least partially by disagreement between lipoprotein particle and cholesterol
measures. LDL-P concentration can be modest in the face of elevated LDL-C (when LDL-P
are particularly cholesterol-rich) and conversely can be substantial despite low LDL-C
concentrations when LDL-P are cholesterol-depleted. In adult longitudinal studies, increased
carotid intima media thickness and incident CVD events are more strongly predicted by
baseline LDL-P assessed by apoB, nuclear magnetic resonance (NMR), or ion mobility, than
by either LDL-C or non-HDL-C.(6, 7)
Although levels and correlates of LDL-P have been recently described in small cohorts of
children,(8) data from a population-based pediatric evaluation of sufficient size to permit
assessment of discordance between cholesterol and lipoprotein particle measures have not
been variable. This report evaluates the lipid and lipoprotein particle characteristics in a
well-characterized, diverse, school-based cohort of 6th graders,(9) and characterizes the
clinical traits that are associated with the LDL-P burden.
METHODS
HEALTHY, a cluster randomized trial designed to investigate the effectiveness of an
integrated lifestyle intervention in middle schools in the reduction of risk factors for type 2
diabetes (T2DM), has been described in full.(9) Schools were the unit of randomization,
intervention, and analysis. Major inclusion criteria for schools were at least 50% of children
eligible for federally subsidized, free or reduced-priced meals and/or at least 50% of its
students whose race/ethnicity was black or Hispanic. The study was approved by the
institutional review boards of all participating research institutions. All children for whom
data were collected provided assent with parental consent. Baseline data on 6th graders
incorporated into these analyses include anthropometric measures, blood pressure, fasting
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insulin, glucose and lipid profiles. Fasting blood draws were ensured using a two step
procedure: (1) the evening before data collection, the study staff called the students
scheduled for the next day’s blood draws to remind them not to eat any food or drink
anything except water after midnight and not to eat breakfast and (2) at check-in, students
were questioned about the last time they had anything to eat or drink and those who
indicated they had not fasted were rescheduled but still received their incentive. To rule out
any confounding of non-fasting sampling on glucose, insulin, or triglyceride values, a full
sensitivity analysis was performed excluding any subjects with a baseline glucose over 99
mg/dl and no study conclusions were altered. The principle outcome variable in this report,
the LDL particle, is not affected by the fasting state. Pubertal status was individually self-
reported in private using the validated Pubertal Development Scale(10) and converted to
pubertal stage groups that are consistent with the five pubertal stages that have been outlined
by Tanner. The homeostatic model of insulin resistance (HOMA-IR) was calculated to
estimate insulin resistance using the formula: fasting glucose [mmol/L] × fasting insulin
[µU/L] ÷ 22.5.
Plasma samples were collected in EDTA after a 12–14 hour fast and were separated on the
morning of collection by centrifugation (2500 rpm, 4° C, 20 min). Lipid profiles including
total cholesterol (TC), triglycerides (TG), and high density lipoprotein cholesterol (HDL-C)
were measured by CDC-standardized direct assay. LDL-C was estimated using the
Friedewald formula. Lipoprotein particle profiles were measured on archived frozen
specimens by NMR spectroscopy using the LipoProfile-3 algorithm at LipoScience, Inc.
(Raleigh, NC).(6) Very low density lipoprotein (VLDL), LDL, and HDL particle subclasses
were quantified from the amplitudes of their spectroscopically-distinct lipid methyl group
NMR signals. VLDL-P, LDL-P, and HDL-P are the totals of the particle number
concentrations of their respective subclasses and their weighted-average particle sizes were
calculated from the sum of the diameter of each subclass multiplied by its relative mass
percentage estimated from the amplitude of its methyl NMR signal.(11) Results reported are
from the 2384 6th grade HEALTHY participants who provided informed consent for
ancillary studies and for whom a frozen specimen was available for analysis.
Statistical Analyses
Means (±SD), medians (±quartile) or frequency distributions (for categorical variables) were
used to summarize the characteristics for the complete sample. Percentile distributions of
LDL-C and LDL-P were calculated and participants defined as having concordant or
discordant levels if the difference between the two measures of LDL quantity were ≤ 20 or
>20 percentile units, respectively. Any definition of discordance is unavoidably subjective;
we considered a difference of >20 percentile units to be reflective of a clinically meaningful
difference in LDL burden. For example, an LDL-c at 75th percentile, if associated with an
LDL-P at 95th percentile, might reflect the risk associated with the 95th percentile of LDL-C,
and visa versa. Regression models were fit for the association of concordance/discordance
status with sex and race/ethnicity using the PROC GLIMMIX procedure and with
anthropometric and lab values using the PROC MIXED procedure.(12) To adjust for the
clustering of participants within schools, a random effect was included in the models. All
models were adjusted for pubertal stage and sex was added as an additional covariate to all
models except those assessing association between sex and discordance/concordance status.
P-values along with adjusted means and 95% confidence intervals are reported. Whenever
exploratory statistically significant group differences were found (p<.05), Bonferroni
adjusted pair-wise comparisons were carried out to determine where the actual differences
lie. Due to skewness, insulin, cholesterol molecules per LDL-P, HDL-P, TG and VLDL-P
size were log transformed and LDL-P and VLDL-P were square root transformed to
distribute data normally. The distributions for LDL-P size and HDL-P size were non-
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transformable and could not be subjected to the regression models although means and 95%
confidence intervals are reported. When considered as a dichotomous variable above or
below 75 nmol/L however, small LDL-P associated significantly with LDL-P > 75th
percentile, and with all variables associated with LDL-P (data not shown). Spearman rank
correlations were estimated to assess the associations of LDL-C and LDL-P with clinical
and laboratory characteristics, unadjusted for cluster of participants within schools. To
illustrate how often discordant lipoprotein phenotypes might be missed by standard LDL or
non-HDL cholesterol values, a cross tabulation of LDL-P in the 1st quartile, 2nd quartile, 3rd
quartile, between the 75th and 95th percentile and above the 95th percentile for our sample
with the equivalent breaks for LDL-C and non-HDL-C is presented with frequencies and
percentage of participants in each category. As previously reported,(13) the power
calculation for this study was based on detecting change in the prevalence of overweight and
obesity. As such the p-values reported within this paper represent findings associated with
secondary outcomes and are provided to help facilitate the interpretation of the data only
with alpha set at 0.05. All analyses were performed using SAS version 9.2 (SAS Institute,
Cary, NC).
RESULTS
Baseline demographic, metabolic and lipoprotein characteristics from an ethnically diverse
population of 2384 6th grade children (mean age 11.3 ± 0.57 years) are presented in the first
column of Table I. Data stratified by sex can be viewed in Table II (available at
www.jpeds.com); the only clinically significant difference between males and females was
Tanner stage. Puberty was more advanced in females, with 81.1% at or beyond Tanner 3 (vs.
43.9% in males). Over 30% of the cohort were obese (BMI >95th percentile) and 12.8%
reported a positive first degree family history of diabetes. Numerous cardiometabolic risk
factors showed a shift toward a higher risk profile, with a mean BMI percentile of 72.9 ±
28.0%, mean waist circumference (WC) above the 75th percentile and mean systolic and
diastolic blood pressures which approximated the 60th percentile for 11 year olds, as defined
by NHANES III.(14) Fasting glucose and insulin levels were elevated in this peripubertal
population as compared with NHANES data, (15) consistent with the insulin resistance
associated with the later stages of puberty.(16) Furthermore, there was evidence of
progression towards pathologic insulin resistance for many children with 17.0% having
impaired fasting glucose, 17.0% with fasting insulin levels ≥ 138.9 pmol/L (> 20 µU/ml) and
14.6% with HOMA-IR ≥ 5.0.
Median and interquartile ranges for TC and HDL-C correspond very closely to those
identified for American preadolescent children by the 1981 Lipid Research Clinic (LRC)
Pediatric Prevalence Study (as reported for 10 to 14 year olds).(17) However, median and
75th percentile values for LDL-C were 6 and 10 % lower and fasting TG levels were 26 and
16% higher (for boys and girls respectively, data not shown) as compared with the LRC
norms.
The median LDL-P concentration for the overall population (Table I) was 677 nmol/L (IQR
512– 885), approximately half of the 50th percentile value (1300 nmol/L) described in
adults, 30 to 74 yr of age.(6) When all of the interrelated elements of lipoprotein metabolism
were included in a correlation matrix (Table III), the characteristics of children predisposed
to higher LDL-P closely resemble what has been described in adults.(18) The strongest
relationships (|r| > 0.45, all at p < 0.0001) were correlations between LDL-P and non-HDL-
C (r = 0.74), LDL-C (r = 0.66), and the TG/HDL-C ratio (r = 0.47) with inverse
relationships evident between LDL-P and both LDL size (r = −0.48) and HDL size (r =
−0.64). The well described relationship between HOMA-IR and BMI z-score (used in lieu of
percentile to normalize the upper range of distribution) was also evident (r = 0.65), and both
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of these variables were more closely associated with LDL-P than either LDL-C or non-
HDL-C.
The percentile difference between LDL-P and LDL-C was relatively normally distributed
with discordance in some children exceeding ± 50 percentile units (Figure). 1116 (46.8%)
children had LDL-P and LDL-C values within 12 percentile units, almost identical to the
50% reported for adults in a multi-ethnic population.9 LDL-C exceeded LDL-P by >20
percentile units in 428 (18.0%) participants, identifying a group of children with relatively
cholesterol-rich lipoprotein particles. LDL-P percentile exceeded LDL-C by the same
margin in 375 children (15.7%) who have LDL particles that are cholesterol-poor.
Table I shows that children in the subgroups defined by concordance or discordance
between LDL-P and LDL-C differ significantly in the prevalence of other cardiovascular
risk factors. The discordant subgroup with LDL-P > LDL-C had significantly higher BMI
percentile, waist circumference, fasting insulin, HOMA-IR, and TG, but lower TC, LDL-C,
and HDL-C than both other subgroups. The opposite characteristics, lower BMI percentile,
waist circumference, fasting insulin and HOMA-IR and TG but higher HDL-C also
distinguished the LDL-P < LDL-C subgroup from the concordant subgroup. Non-HDL-C in
the LDL-P < LDL-C subgroup was significantly higher than in the concordant and LDL-P >
LDL-C discordant subgroups, but did not distinguish the latter two groups from one another.
Systolic and diastolic blood pressure were higher and Hispanic ethnicity more common, and
black race was less common in the LDL-P > LDL-C discordant and concordant subgroups
than in the LDL-P < LDL-C discordant subgroup, but did not distinguish the latter two
groups.
In light of the strength such a robust data set offers for these comparative analyses, the few
features in Table I that did not vary by concordant-discordant category are notable: sex
(after adjustment for Tanner stage), white race, and fasting blood glucose were similar
among all subgroups. The skewed distribution of LDL and HDL particle size did not permit
statistical analysis by subgroup, but mean values rose across the LDL-P > LDL-C discordant
to concordant to the LDL-P < LDL-C subgroups.
Cross tabulation of LDL-C and LDL-P variables (Table IV) illustrates that discordant
lipoprotein phenotypes might be missed by a standard focus on either LDL or non-HDL
cholesterol values, particularly when LDL-P exceeds LDL-C. In this cohort, 14% of the
1777 children with LDL-C < 102 mg/dl and 12% with non-HDL-C < 122 mg/dl (both < 75th
percentile) had LDL-P > 75th percentile (> 886–2672 nmol/L). Four percent of children with
LDL-C < 86 mg/dl and 2% with non-HDL-C < 102 mg/dl (both < 50th percentile) still had
LDL-P above the 75th percentile. Conversely, 22% of 120 children with LDL-C > 126 mg/dl
and 11% with non-HDL-C > 150 mg/dl (both > 95th percentile), but no children with LDL-C
above the 99th percentile (160 mg/dl), had LDL-P < 75th percentile.
Clinical and metabolic variables together with elements of the lipid profile, other than LDL-
C, can give considerable insight to the cardiovascular risk burden of LDL-P. In a
multivariate model considering all correlates of LDL-P, 66.6% of the variation could be
explained by the combination of waist circumference, TG/HDL-C, non-HDL-C and HOMA-
IR.
DISCUSSION
This study confirms the existence of wide variability in cholesterol content of low density
lipoproteins in a large, diverse, school-based cohort, and suggests that the frequency with
which measures of lipoprotein cholesterol content either under or overestimate lipoprotein
particle concentration is very similar to what has been described in adults.(6) This does not
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refute decades of evidence supporting the absolute role of cholesterol in atherogenesis, but
rather helps accentuate the importance of the apoB-tagged lipoprotein particle (apoB Lp)
carriers of cholesterol for sterol infiltration within the vascular space.(19) Because all
lipoproteins except for HDL-P contain apoB, the simple calculation of non-HDL-C is a
surrogate measure for apoB that includes LDL-C and the more transient intermediate density
lipoprotein cholesterol (reported in the LDL component of a lipid profile) and VLDL-C.(20)
The hypertriglyceridemia of insulin resistance drives up large VLDL-C that are metabolized
to small LDL, increasing LDL-P. Therefore, non-HDL-C correlates with LDL-P better than
does LDL-C, but the correlation can still be moderately discordant in as many as 30% of
adults(7) and in 12% of children in this cohort. Because the half life of LDL-P is
considerably longer than for other apoB-containing lipoproteins,(21) LDL-P are closely
approximated by apoB levels. ApoB levels were not measured in the HEALTHY cohort but
very similar relationships would have been anticipated to what is described here for LDL-P.
These findings may have relevance to the interpretation of pediatric lipid levels. Therapeutic
interventions may be considered on the basis of elevated LDL-C or non-HDL-C levels (22)
though CVD risk may be mitigated by a disproportionately smaller lipoprotein particle
burden when LDL-P < LDL-C, with correspondingly fewer cardiometabolic risk factors.
Conversely, when LDL-P > LDL-C, as recently discovered in the increasingly prevalent
dyslipidemia of childhood obesity complicated by insulin resistance,(8) a significant burden
of cardiometabolic risk may be underestimated based on normal or minimally elevated
cholesterol levels.
Currently, adult risk score models aim to identify and treat persons at heightened CVD risk
within ten years. Once adults enter a high risk pool, however, they have already had decades
of accumulated subclinical disease, reducing the impact of most available interventions and
at best only postponing a coronary event.(23) A more preemptive “causal exposure model”
has been proposed to actively prevent subclinical progression of disease by treating known
causes of CVD as soon as they are identified.(23, 24) Adolescents with combined
dyslipidemia, defined as a TG/HDL-C ratio greater than only 2.5, are more likely to express
a proatherogenic lipid profile in early adulthood.(25) An unsettling plateau in the net rate of
CVD deaths among young adults, ages 35- 54 yr,(26) can be traced to the steady rise in
childhood obesity and diabetes over the last 4 decades, reflected in the strong association
between non-HDL-C and cardiometabolic risk.(27) LDL-P is a sensitive biomarker for the
disordered lipoprotein cholesterol and triglyceride metabolism associated with central
obesity and insulin resistance, and appears to be operative in this rising prevalence of CVD.
(7, 28) Much of the variation in LDL-P levels in HEALTHY study children was associated
with the same combination of cardiometabolic factors that place adults at high CVD risk,
namely insulin resistance, visceral adiposity, hypertension, and combined dyslipidemia.
A lower absolute LDL-P burden in children has been previously described,(8) but most
pediatric studies to date have focused not on LDL-P concentration but rather on its close
correlate, the LDL particle size. LDL size heightens cardiovascular risk because small LDL
are cleared from the circulation by LDL receptors with ½ to 1/3 the efficiency of larger
LDL.(29) When insulin resistance impairs TG clearance and the liver generates larger and
more TG-rich VLDL to compensate, particles themselves too large to enter the vascular
wall, they are quickly metabolized to small LDL that linger longer in the vascular space with
increased opportunity to foment atherogenesis. The larger mean LDL particle size and lower
LDL-P concentration in youth as compared with adults may therefore contribute to the lag
time between the onset of atherogenesis and the development of symptomatic CVD.
Reproducible and reliable early surrogates for cardiovascular disease will be necessary to
delineate the dose-response for LDL-P associated CVD risk in youth, but current preventive
pediatric cardiology guidelines for standard lipid profile screening and management(2, 30)
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provide insight into a disproportionate LDL-P burden however by highlighting moderate and
high level “non-lipid” risk factors. In the HEALTHY cohort, the subgroup with LDL-P >
LDL-C had significantly higher prevalence of features of the metabolic syndrome, including
elevated TG, low HDL-C, systolic and diastolic hypertension and hyperinsulinism but not
hyperglycemia. Insulin resistance drives the hyperinsulinism of youth that masks glucose
elevation, but cannot attenuate full cardiometabolic sequelae. Additional non-lipid risk
factors such as family history, obesity, and diabetes all heighten the hazard associated with
either LDL-C or non-HDL-C elevation. These are not only children who fall in the moderate
LDL-C risk zone between 110 and 130 mg/dl, or comparable non-HDL-C risk zone between
125 and 145 mg/dl. In this cohort, 14% of children with LDL-C < 102 mg/dl and 12% with
non-HDL-C < 122 mg/dl (both < 75th percentile) had LDL-P > 75th percentile. The adjusted
mean LDL-P concentration in this subgroup was 888 (95% CI=853–923), 24% higher than
the mean for the 6th grade population overall, and the 95th percentile crossed the 1100 nmol/
L threshold set as a target for LDL-P reduction in high-risk adults.(7)
If there is good insulin sensitivity, a normal waist circumference, low non-HDL-C and TG/
HDL-C, a lower LDL-P burden can be predicted across a wide range of LDL-C levels. At
LDL-C up to the 95th percentile (126 mg/dl in this cohort), 50% of children still have LDL-
P below the 75th percentile. Among the HEALTHY cohort, children with levels of LDL-C
that exceed the current conservative pharmacologic treatment threshold of 160 mg/dl (99th
percentile) however, levels that might be associated with familial hypercholesterolemia, all
fall into a significantly elevated (>95th percentile) LDL-P category.
Although absolute LDL-P levels differ, the prevalence of discordance between LDL-C and
LDL-P seen in children was comparable with what has been described in adults. These
findings are not self-evident and suggest that a confluence of genetic and epigenetic factors
may underlie this trait, just as genes involved in lipid metabolism contribute to absolute
cholesterol and triglyceride levels. Forty-three genetic loci have been associated with plasma
lipoprotein size, concentration and cholesterol content in a genome-wide analyses on 17,296
adults of European ancestry.(31) These hereditary factors can only explain a small fraction
of lipid variability but may already be manifest in the lipid phenotype in youth and may be
functional in the apparent differences in LDL phenotype previously described among
children of different race and ethnicity.(8, 32) Our findings are consistent with a greater
LDL-P burden in children of Hispanic ethnicity as compared with white or black race but
the sample size was inadequate for definitive subgroup analyses.
As the HEALTHY study targeted minority middle school children at heightened risk for
obesity, the findings herein are most relevant to comparable inner city youth who, for the
complex reasons that underpin health disparity, remain at heightened risk for both obesity
and its cardiometabolic complications.(33) Notwithstanding intertwined hereditary and
socioeconomic determinants, the same anthropometric and metabolic factors known to
influence the absolute levels of cholesterol, triglycerides and lipoprotein species across the
lifespan, are predictive of the absolute LDL-P burden both in adults(18) and in this
multiethnic cohort of school children. These risk factors are sensitive to lifestyle. Nutrition
and exercise interventions that improve insulin sensitivity and weight distribution in adults
also improve the lipid phenotype.(34, 35) The atherogenic combined dyslipidemia of
childhood obesity, which elevates the TG/HDL-C ratio and non-HDL-C in the context of
visceral obesity and insulin resistance, is associated with a discordant, high-risk LDL
particle phenotype. This LDL-P > LDL-C pattern, with putative atherogenic consequences,
is often missed if only LDL-C is considered. Conversely, many children with moderate risk
cholesterol profiles (in the 75th to 99th percentile) but optimal weight and insulin sensitivity
may have a lower than apparent LDL-P burden. Children who meet current pediatric criteria
for pharmacologic lipid management will most likely have very elevated LDL-P levels.
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Amount of agreement/disagreement between LDL-P and LDL-C as differences in the
sample percentiles for each and the percent of the sample that falls into each range of
differences. There is relative agreement or concordance for two-thirds of the study group in
whom LDL-C and LDL-P percentiles fall within 20 percentile points. The two measures
disagree or are discordant for the rest of the study group, varying from 20 to 80 percentile
points.
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